Vijaya Diagnostic Centre Ltd
Vijaya Diagnostic Centre Q2 Results 2026 (FY27) investor presentation: Revenue & Margins
Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.
Guidance rank: #10 of 32 in Healthcare Services
See the sector's top 10 — free with your mobile number.
Vijaya Diagnostic Centre Ltd Q2 FY27 key numbers
- Revenue
- Q2 FY27 Revenue from Operations: INR 2,554 Mn, up 26.7% YoY.
As stated in Vijaya Diagnostic Centre Ltd's Q2 FY27 investor presentation · published 3 Nov 2026. Reported figures, not investment advice.
Based on Vijaya Diagnostic Centre Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q2 FY27 Revenue from Operations: INR 2,554 Mn, up 26.7% YoY (Page 10, 9). Quarter (Q2 FY27) EBITDA: INR 1,128 Mn.
From Vijaya Diagnostic Centre Ltd's Q2 FY27 earnings-call transcript · updated 3 Nov 2026.
How did Vijaya Diagnostic Centre's revenue grow in the September 2026 quarter?
- Q2 FY27 Revenue from Operations: INR 2,554 Mn, up 26.7% YoY (Page 10, 9)
- Q2 FY27 Test Volume: 4.98 million tests, up 16.5% YoY (Page 10, 9 & Page 5, 4)
- Q2 FY27 Footfalls: 1.37 million, up 14.5% YoY (Page 9, 8 & Page 5, 4)
- Revenue per Test in Q2 FY27: INR 513 (Page 9, 8)
- Management commentary (Page 7, 6) states ongoing strong growth momentum with 26.7% YoY revenue growth and 16.5% volume growth in Q2 FY27.
2 more points from Vijaya Diagnostic Centre Ltd's call on revenue
Create a free account to keep reading this call
What happened to Vijaya Diagnostic Centre's margins in Q2 FY27?
See what Vijaya Diagnostic Centre Ltd said on profitability & margins — free account, 30 seconds.
What capex is Vijaya Diagnostic Centre planning?
- The company plans strategic expansion through new hubs and spokes across various regions as per pages 22-23:
- H1 FY27: 1 Hub and 4 Spokes in RoAPT (Rest of AP and Telangana); 1 Spoke in Hyderabad launched
- H2 FY27: Multiple Spokes and Hubs including 1 Hub & 4 Spokes in Hyderabad, 2 Spokes & 1 Hub in Bengaluru, 1 Spoke in Pune, 2 Hubs & 7 Spokes in West Bengal, and others in Mysore and Gurugram
- Q1 FY28: 3 Hubs and 7 Spokes in Mysore planned
- Acquisition of PH, Pune’s largest B2C integrated diagnostic chain, completed to enhance presence in Pune (Page 22).
- Acquisition of Arya Wellness to enter North-East India and expand Eastern presence (Page 18).
2 more points from Vijaya Diagnostic Centre Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is Vijaya Diagnostic Centre raising money or cutting debt?
See what Vijaya Diagnostic Centre Ltd said on fundraising & capital structure — free account, 30 seconds.
How big is Vijaya Diagnostic Centre's order book?
See what Vijaya Diagnostic Centre Ltd said on order book & pipeline — free account, 30 seconds.
Vijaya Diagnostic Centre Ltd — Quarterly revenue & net profit
Q2 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q2 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹219 Cr, net profit ₹48 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Vijaya Diagnostic Centre's management said in earlier quarters
- Q3 FY26 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q4 FY26 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q4 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
Others in Healthcare Services this season
- Shalby (Q2 FY27)
Consolidated Total Revenue for Q2 FY27: ₹3,182 million vs ₹2,899 million in Q2 FY26, up 9.8% YoY (Pages 5, 6, 8, 9) . Key investor presentation takeaways from S
- Metropolis Healt (Q2 FY27)
Q2FY27 revenue from operations: INR 496.8 Cr, up 15.8% YoY (Page 11) . Key investor presentation takeaways from Metropolis Healthcare Ltd's Q2 FY27 investor pre
- Nephrocare Health Services (Q2 FY27)
Q2 FY27 Revenue from Operations: ₹303.4 Cr, up 23.5% YoY from ₹245.7 Cr in Q2 FY26 (Page 9). Key investor presentation takeaways from Nephrocare Health Services
- Global Health Ltd (Q2 FY27)
Q2 FY2027 revenue from operations: INR 14,690 million, up 33.6% year-on-year (YoY). Key investor presentation takeaways from Global Health Ltd's Q2 FY27 investo
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM Quality Care LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Vijaya Diagnostic Centre Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Vijaya Diagnostic Centre Ltd Q2 FY27 results?
Q2 FY27 Revenue from Operations: INR 2,554 Mn, up 26.7% YoY (Page 10, 9). Quarter (Q2 FY27) EBITDA: INR 1,128 Mn.
What is Vijaya Diagnostic Centre Ltd share price analysis?
Vijaya Diagnostic Centre Ltd currently shows a neutral. The stock trades at a P/E of 79.5 with a market cap of ₹14,905 Cr. Investors should review the full earnings analysis for detailed insights.
Is Vijaya Diagnostic Centre Ltd planning capital expenditure?
The company plans strategic expansion through new hubs and spokes across various regions as per pages 22-23:.
Keep Vijaya Diagnostic Centre Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.